The research on the relationship between fat and metastasis performed by Salvador Aznar Benitah and Gloria Pascual at IRB Barcelona figures among the eight studies competing in the 7th "La Vanguardia de la Ciencia" Prize—an award that seeks to give greater visibility to research of excellence. Until 28 February, readers will be able to vote for the study they consider most important.
The newspaper explains that "A strategy against metastasis" is a study that may be relevant for both the prevention and treatment of cancer. Salvador Aznar-Benitah and Gloria Pascual have identified a protein that appears to be crucial for the development and growth of metastases. The translation of this protein to clinical practice is currently being studied. The study was published in the journal Nature in December 2016.
If you want to vote, click on the following link: Los lectores eligen la mejor ciencia del año (Spanish)
About IRB Barcelona
Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).